By Berna Namata Rwanda could become the first country in Africa to effectively fight cervical cancer following the launch of a comprehensive national prevention programme last week. Rwanda will be the first country in Africa to offer a national prevention programme that includes the most advanced technologies and tools to protect girls and women from […]
Africa's Rwanda Gets Merck Cervical Prevention Treatment
The land of Africa is the second largest continent in the world in both square mileage and population. Thus, it also has widespread disease and in turn, is a huge testing bed for new medications and procedures. This week Merck and Qiagen NV have announced collaboration in Rwanda to battle cervical cancer. Rwanda will be […]
Merck, Qiagen Begin Rwandan Cervical-Cancer Program, Times Says
By Heather Murdock Merck & Co. and Qiagen NV (QGEN) will fund a program in Rwanda to screen and vaccinate women against cervical cancer, the New Times reported, citing Agnes Binagwaho, permanent secretary in the Health Ministry. Merck will provide more than 2 million doses of its Gardasil vaccine to the government at no charge, […]
Merck, Qiagen launch Rwandan cervical cancer deal
By Kate Kelland, Health and Science Correspondent * Merck to donate 2 million doses of Gardasil HPV vaccine * Qiagen to give 250,000 tests for women aged 35-45 * Rwanda to pay “dramatically” cut price after first 3 years LONDON, April 25 (Reuters) – U.S. drugmaker Merck and German diagnostics firm Qiagen are donating millions […]
Rwanda: Over 100,000 Schoolgirls to Get Cervical Cancer Vaccine
By Edwin Musoni About 100,000 girls in primary schools will benefit from a new vaccine against Human Papilloma Virus (HPV) which causes cervical cancer. This was revealed by the head of adolescent and reproductive health in the Ministry of Health, Dr. Diane Mutamba, in an interview with The New Times. “The official launch of the […]
